PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826F07Y8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $344,035
Award facts
- Contract value 100% obligated
- $344,034.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $344,034.88 on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price contract, issued without a set-aside designation, was funded by the Defense Logistics Agency's Medical Supply Chain division. The delivery order represents task work under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
The specific deliverables under this delivery order align with AmerisourceBergen's established federal procurement role, which encompasses specialty medications, brand-name and generic drugs, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's extensive portfolio of federal contracts demonstrates its capability to efficiently fulfill government requirements for essential pharmaceutical and medical supplies required by military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The parent entity, Cencora, Inc. (doing business as AmerisourceBergen), maintains a significant IDC with DLA valued at up to $999,999,999.00 through December 2031, further establishing the company's critical role in the federal medical supply chain.
Quick answers
Who was awarded contract SPE2D826F07Y8?
SPE2D826F07Y8 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 12, 2026.
How much is contract SPE2D826F07Y8 worth?
The government has obligated $344,035 on SPE2D826F07Y8.
Is contract SPE2D826F07Y8 an order under another contract?
Yes. SPE2D826F07Y8 is a delivery order under SPE2DX22D0069, an indefinite delivery contract.
Was contract SPE2D826F07Y8 competed?
The extent of competition for SPE2D826F07Y8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award